Study Evaluating Safety & Efficacy of Subcutaneous Methylnaltrexone on Opioid-Induced Constipation in Cancer Subjects

Summary

This purpose of this study is to evaluate the safety and effectiveness of a subcutaneous (injection beneath the skin) form of methylnaltrexone in subjects who have cancer-related pain and constipation from taking opioids. The length of participation will be up to 7 weeks.

Timeline

Start

2009-03

Primary completion

2009-08

Completion

2009-08

Outcome

Outcome not reported

Stopped (Business): “Withdrawn \[This study was terminated early by Wyeth, prior to dosing any subjects, for business reasons not related to safety.”

Drugs

Indications